Inhalation by design: novel ultra-long-acting β(2)-adrenoreceptor agonists for inhaled once-daily treatment of asthma and chronic obstructive pulmonary disease that utilize a sulfonamide agonist headgroup.

Inhalation by design: novel ultra-long-acting β(2)-adrenoreceptor agonists for inhaled once-daily treatment of asthma and chronic obstructive pulmonary disease that utilize a sulfonamide agonist headgroup.

Item
http://www.wikidata.org/entity/Q34134830
β(2) -adrenoceptor agonists: current and future directionInvestigational beta-2 adrenergic agonists for the treatment of chronic obstructive pulmonary disease.Predicted heart rate effect of inhaled PF-00610355, a long acting β-adrenoceptor agonist, in volunteers and patients with chronic obstructive pulmonary disease.Dual-pharmacology muscarinic antagonist and β₂ agonist molecules for the treatment of chronic obstructive pulmonary disease.Third-generation long-acting β₂-adrenoceptor agonists: medicinal chemistry strategies employed in the identification of once-daily inhaled β₂-adrenoceptor agonists.What is the potential for inhaled p38 inhibitors in the treatment of chronic obstructive pulmonary disease?A perspective on synthetic and solid-form enablement of inhalation candidates.Emerging drugs for chronic obstructive pulmonary disease.Emerging drugs for asthma.Update on ultra-long-acting β agonists in chronic obstructive pulmonary disease.Concise asymmetric syntheses of novel phenanthroquinolizidines.Longitudinal FEV1 dose-response model for inhaled PF-00610355 and salmeterol in patients with chronic obstructive pulmonary disease.G-protein coupled receptor and kinase targets: advances in drug discovery from molecular to clinical.Optimized glucuronidation of dual pharmacology β-2 agonists/M3 antagonists for the treatment of COPD
P2860

Inhalation by design: novel ultra-long-acting β(2)-adrenoreceptor agonists for inhaled once-daily treatment of asthma and chronic obstructive pulmonary disease that utilize a sulfonamide agonist headgroup.

Item
http://www.wikidata.org/entity/Q34134830
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Inhalation by design: novel ultra-long-acting β
@nl
Inhalation by design: novel ul ...... sulfonamide agonist headgroup.
@ast
Inhalation by design: novel ul ...... sulfonamide agonist headgroup.
@en
type
label
Inhalation by design: novel ultra-long-acting β
@nl
Inhalation by design: novel ul ...... sulfonamide agonist headgroup.
@ast
Inhalation by design: novel ul ...... sulfonamide agonist headgroup.
@en
prefLabel
Inhalation by design: novel ultra-long-acting β
@nl
Inhalation by design: novel ul ...... sulfonamide agonist headgroup.
@ast
Inhalation by design: novel ul ...... sulfonamide agonist headgroup.
@en
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P50
P577
P698
P921
P356
P1433
P1476
Inhalation by design: novel ul ...... sulfonamide agonist headgroup
@en
P2093
P304
P31
P356
P407
P433
P478
P50
P577
P698
P921